1. Home
  2. FEMY vs EBON Comparison

FEMY vs EBON Comparison

Compare FEMY & EBON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEMY
  • EBON
  • Stock Information
  • Founded
  • FEMY 2004
  • EBON 2010
  • Country
  • FEMY United States
  • EBON China
  • Employees
  • FEMY N/A
  • EBON N/A
  • Industry
  • FEMY Medical/Dental Instruments
  • EBON Semiconductors
  • Sector
  • FEMY Health Care
  • EBON Technology
  • Exchange
  • FEMY Nasdaq
  • EBON Nasdaq
  • Market Cap
  • FEMY 31.9M
  • EBON 25.3M
  • IPO Year
  • FEMY 2021
  • EBON 2020
  • Fundamental
  • Price
  • FEMY $0.95
  • EBON $4.67
  • Analyst Decision
  • FEMY Strong Buy
  • EBON
  • Analyst Count
  • FEMY 3
  • EBON 0
  • Target Price
  • FEMY $8.67
  • EBON N/A
  • AVG Volume (30 Days)
  • FEMY 361.1K
  • EBON 17.0K
  • Earning Date
  • FEMY 08-07-2025
  • EBON 08-22-2025
  • Dividend Yield
  • FEMY N/A
  • EBON N/A
  • EPS Growth
  • FEMY N/A
  • EBON N/A
  • EPS
  • FEMY N/A
  • EBON N/A
  • Revenue
  • FEMY $1,699,232.00
  • EBON $5,868,771.00
  • Revenue This Year
  • FEMY $231.84
  • EBON N/A
  • Revenue Next Year
  • FEMY $245.28
  • EBON N/A
  • P/E Ratio
  • FEMY N/A
  • EBON N/A
  • Revenue Growth
  • FEMY 61.97
  • EBON 20.88
  • 52 Week Low
  • FEMY $0.69
  • EBON $3.00
  • 52 Week High
  • FEMY $1.80
  • EBON $10.94
  • Technical
  • Relative Strength Index (RSI)
  • FEMY 50.88
  • EBON 75.89
  • Support Level
  • FEMY $0.90
  • EBON $3.28
  • Resistance Level
  • FEMY $0.99
  • EBON $3.49
  • Average True Range (ATR)
  • FEMY 0.07
  • EBON 0.31
  • MACD
  • FEMY 0.01
  • EBON 0.09
  • Stochastic Oscillator
  • FEMY 39.48
  • EBON 95.54

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About EBON Ebang International Holdings Inc.

Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.

Share on Social Networks: